Catalent Stock EBITDA

CTLT Stock

USD 56.08 0.22 0.39%

Catalent fundamentals help investors to digest information that contributes to Catalent's financial success or failures. It also enables traders to predict the movement of Catalent Stock. The fundamental analysis module provides a way to measure Catalent's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Catalent stock.

		Last Reported	Projected for Next Year
	EBITDA	90.8 M	86.3 M

EBITDA is likely to drop to about 86.3 M in 2024.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Catalent Company EBITDA Analysis

Catalent's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

EBITDA

Revenue

-

Basic Expenses

More About EBITDA | All Equity Analysis

Current Catalent EBITDA

79 M

Most of Catalent's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Catalent is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Catalent EBITDA Driver Correlations

Understanding the fundamental principles of building solid financial models for Catalent is extremely important. It helps to project a fair market value of Catalent Stock properly, considering its historical fundamentals such as EBITDA. Since Catalent's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Catalent's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Catalent's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Good Will	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Net Tangible Assets	Total Permanent Equity	Short Term Investments	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock	Long Term Investments
Total Assets		0.89	0.84	0.79	0.91	1.0	0.91	0.98	0.99	0.96	0.98	0.6	0.95	0.93	0.88	0.84	0.75	0.8	0.92	0.97	0.65	-0.46	0.82	0.86	0.27	0.87
Total Stockholder Equity	0.89		0.79	0.64	0.99	0.9	0.77	0.9	0.88	0.83	0.89	0.75	0.83	0.9	0.99	0.95	0.85	0.92	0.78	0.92	0.72	-0.58	0.84	0.87	0.22	0.9
Current Deferred Revenue	0.84	0.79		0.39	0.8	0.86	0.63	0.92	0.84	0.77	0.91	0.34	0.81	0.87	0.73	0.81	0.8	0.63	0.64	0.87	0.41	-0.58	0.85	0.87	0.56	0.73
Net Debt	0.79	0.64	0.39		0.66	0.78	0.94	0.68	0.77	0.87	0.67	0.71	0.73	0.6	0.72	0.52	0.4	0.72	0.93	0.65	0.78	0.01	0.45	0.48	-0.22	0.75
Retained Earnings	0.91	0.99	0.8	0.66		0.91	0.79	0.92	0.89	0.83	0.91	0.68	0.84	0.91	0.97	0.96	0.84	0.93	0.79	0.92	0.73	-0.59	0.88	0.89	0.16	0.91
Accounts Payable	1.0	0.9	0.86	0.78	0.91		0.91	0.99	0.99	0.96	0.98	0.59	0.94	0.93	0.88	0.84	0.76	0.81	0.91	0.97	0.65	-0.46	0.83	0.87	0.29	0.88
Long Term Debt	0.91	0.77	0.63	0.94	0.79	0.91		0.85	0.9	0.97	0.84	0.65	0.88	0.73	0.82	0.64	0.57	0.78	1.0	0.79	0.77	-0.12	0.69	0.72	0.04	0.83
Net Receivables	0.98	0.9	0.92	0.68	0.92	0.99	0.85		0.98	0.92	0.99	0.53	0.94	0.96	0.87	0.87	0.82	0.78	0.85	0.98	0.59	-0.55	0.87	0.9	0.35	0.85
Good Will	0.99	0.88	0.84	0.77	0.89	0.99	0.9	0.98		0.96	0.96	0.59	0.98	0.92	0.87	0.81	0.77	0.76	0.91	0.96	0.61	-0.46	0.82	0.84	0.29	0.82
Total Liab	0.96	0.83	0.77	0.87	0.83	0.96	0.97	0.92	0.96		0.91	0.64	0.94	0.81	0.85	0.71	0.66	0.76	0.97	0.88	0.71	-0.23	0.75	0.79	0.23	0.84
Total Current Assets	0.98	0.89	0.91	0.67	0.91	0.98	0.84	0.99	0.96	0.91		0.51	0.91	0.94	0.86	0.87	0.78	0.79	0.85	0.97	0.59	-0.52	0.87	0.92	0.4	0.87
Short Term Debt	0.6	0.75	0.34	0.71	0.68	0.59	0.65	0.53	0.59	0.64	0.51		0.52	0.55	0.81	0.64	0.55	0.79	0.64	0.57	0.73	-0.2	0.32	0.38	-0.14	0.71
Intangible Assets	0.95	0.83	0.81	0.73	0.84	0.94	0.88	0.94	0.98	0.94	0.91	0.52		0.86	0.82	0.72	0.75	0.67	0.89	0.91	0.56	-0.43	0.82	0.81	0.29	0.73
Common Stock	0.93	0.9	0.87	0.6	0.91	0.93	0.73	0.96	0.92	0.81	0.94	0.55	0.86		0.84	0.93	0.85	0.77	0.73	0.98	0.51	-0.73	0.79	0.82	0.27	0.82
Property Plant Equipment	0.88	0.99	0.73	0.72	0.97	0.88	0.82	0.87	0.87	0.85	0.86	0.81	0.82	0.84		0.91	0.79	0.95	0.82	0.87	0.81	-0.46	0.81	0.84	0.14	0.91
Net Tangible Assets	0.84	0.95	0.81	0.52	0.96	0.84	0.64	0.87	0.81	0.71	0.87	0.64	0.72	0.93	0.91		0.84	0.9	0.63	0.9	0.64	-0.71	0.8	0.84	0.2	0.89
Total Permanent Equity	0.75	0.85	0.8	0.4	0.84	0.76	0.57	0.82	0.77	0.66	0.78	0.55	0.75	0.85	0.79	0.84		0.66	0.57	0.83	0.36	-0.76	0.73	0.7	0.29	0.63
Short Term Investments	0.8	0.92	0.63	0.72	0.93	0.81	0.78	0.78	0.76	0.76	0.79	0.79	0.67	0.77	0.95	0.9	0.66		0.76	0.77	0.9	-0.37	0.72	0.77	-0.05	0.96
Long Term Debt Total	0.92	0.78	0.64	0.93	0.79	0.91	1.0	0.85	0.91	0.97	0.85	0.64	0.89	0.73	0.82	0.63	0.57	0.76		0.8	0.75	-0.11	0.7	0.73	0.09	0.81
Capital Surpluse	0.97	0.92	0.87	0.65	0.92	0.97	0.79	0.98	0.96	0.88	0.97	0.57	0.91	0.98	0.87	0.9	0.83	0.77	0.8		0.52	-0.64	0.83	0.87	0.38	0.82
Deferred Long Term Liab	0.65	0.72	0.41	0.78	0.73	0.65	0.77	0.59	0.61	0.71	0.59	0.73	0.56	0.51	0.81	0.64	0.36	0.9	0.75	0.52		0.02	0.57	0.6	-0.25	0.88
Short Long Term Debt	-0.46	-0.58	-0.58	0.01	-0.59	-0.46	-0.12	-0.55	-0.46	-0.23	-0.52	-0.2	-0.43	-0.73	-0.46	-0.71	-0.76	-0.37	-0.11	-0.64	0.02		-0.5	-0.46	-0.25	-0.33
Net Invested Capital	0.82	0.84	0.85	0.45	0.88	0.83	0.69	0.87	0.82	0.75	0.87	0.32	0.82	0.79	0.81	0.8	0.73	0.72	0.7	0.83	0.57	-0.5		0.97	0.39	0.75
Net Working Capital	0.86	0.87	0.87	0.48	0.89	0.87	0.72	0.9	0.84	0.79	0.92	0.38	0.81	0.82	0.84	0.84	0.7	0.77	0.73	0.87	0.6	-0.46	0.97		0.48	0.82
Capital Stock	0.27	0.22	0.56	-0.22	0.16	0.29	0.04	0.35	0.29	0.23	0.4	-0.14	0.29	0.27	0.14	0.2	0.29	-0.05	0.09	0.38	-0.25	-0.25	0.39	0.48		0.05
Long Term Investments	0.87	0.9	0.73	0.75	0.91	0.88	0.83	0.85	0.82	0.84	0.87	0.71	0.73	0.82	0.91	0.89	0.63	0.96	0.81	0.82	0.88	-0.33	0.75	0.82	0.05

Click cells to compare fundamentals

Catalent EBITDA Historical Pattern

Today, most investors in Catalent Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Catalent's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's ebitda growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Catalent ebitda as a starting point in their analysis.

Catalent EBITDA

Timeline

In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.

Competition

Predict Catalent

Ebitda Over Time

Catalent Ebitda

Ebitda

86.31 Million

At this time, Catalent's EBITDA is comparatively stable compared to the past year.

According to the company disclosure, Catalent reported earnings before interest,tax, depreciation and amortization of 79 M. This is 91.0% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The ebitda for all United States stocks is 97.97% higher than that of the company.

Catalent EBITDA Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Catalent's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Catalent could also be used in its relative valuation, which is a method of valuing Catalent by comparing valuation metrics of similar companies.

Catalent is currently under evaluation in ebitda category among related companies.

Catalent Institutional Holders

Institutional Holdings refers to the ownership stake in Catalent that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Catalent's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Catalent's value.

		Shares
Geode Capital Management, Llc	2023-12-31	4 M
Elliott Investment Management L.p.	2023-12-31	4 M
Amvescap Plc.	2023-12-31	3.8 M
Barclays Plc	2023-12-31	3.7 M
Capital Research & Mgmt Co - Division 3	2023-12-31	3 M
Norges Bank	2023-12-31	2.6 M
Northern Trust Corp	2023-12-31	2.1 M
Goldman Sachs Group Inc	2023-12-31	1.8 M
Ameriprise Financial Inc	2023-12-31	1.8 M
Vanguard Group Inc	2023-12-31	20.2 M
Capital World Investors	2023-12-31	19.1 M

Catalent Fundamentals

	Return On Equity	-0.3
	Return On Asset	-0.0075
	Profit Margin	(0.32) %
	Operating Margin	(0.08) %
	Current Valuation	14.96 B
	Shares Outstanding	180.74 M
	Shares Owned By Insiders	0.49 %
	Shares Owned By Institutions	99.51 %
	Number Of Shares Shorted	7.51 M
	Price To Earning	17.80 X
	Price To Book	2.76 X
	Price To Sales	2.48 X
	Revenue	4.28 B
	Gross Profit	1.04 B
	EBITDA	79 M
	Net Income	(256 M)
	Cash And Equivalents	345 M
	Cash Per Share	1.92 X
	Total Debt	4.85 B
	Debt To Equity	0.90 %
	Current Ratio	2.86 X
	Book Value Per Share	20.41 X
	Cash Flow From Operations	261 M
	Short Ratio	3.39 X
	Earnings Per Share	(7.18) X
	Price To Earnings To Growth	2.06 X
	Target Price	56.7
	Number Of Employees	18 K
	Beta	1.19
	Market Capitalization	10.18 B
	Total Asset	10.78 B
	Retained Earnings	518 M
	Working Capital	1.17 B
	Current Asset	790.2 M
	Current Liabilities	391.2 M
	Net Asset	10.78 B

About Catalent Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Catalent's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Catalent using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Catalent based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Pair Trading with Catalent

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Catalent position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Catalent will appreciate offsetting losses from the drop in the long position's value.

Moving against Catalent Stock

0.73	NVS	Novartis AG ADR Earnings Call This Week	Pair Corr
0.68	VALN	Valneva SE ADR Financial Report 2nd of May 2024	Pair Corr
0.67	BNR	Burning Rock BiotechLtd Financial Report 4th of June 2024	Pair Corr
0.53	VRTX	Vertex Pharmaceuticals Financial Report 6th of May 2024	Pair Corr
0.53	IVA	Inventiva Sa	Pair Corr

The ability to find closely correlated positions to Catalent could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Catalent when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Catalent - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Catalent to buy it.

The correlation of Catalent is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Catalent moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Catalent moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Catalent can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Catalent is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Catalent Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Catalent Stock. Highlighted below are key reports to facilitate an investment decision about Catalent Stock:

How To Invest In Catalent

Details

Is Catalent Stock a good investment?

Details

What is Catalent's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Catalent Piotroski F Score and Catalent Altman Z Score analysis.

For more information on how to buy Catalent Stock please use our How to Invest in Catalent guide.

You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Complementary Tools for Catalent Stock analysis

When running Catalent's price analysis, check to measure Catalent's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Catalent is operating at the current time. Most of Catalent's value examination focuses on studying past and present price action to predict the probability of Catalent's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Catalent's price. Additionally, you may evaluate how the addition of Catalent to your portfolios can decrease your overall portfolio volatility.

	Transaction History View history of all your transactions and understand their impact on performance
	Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated
	Risk-Return Analysis View associations between returns expected from investment and the risk you assume
	Money Managers Screen money managers from public funds and ETFs managed around the world
	Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
	Analyst Advice Analyst recommendations and target price estimates broken down by several categories
	Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios
	Share Portfolio Track or share privately all of your investments from the convenience of any device
	Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules
	Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
	Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
	Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios.

Is Catalent's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Catalent. If investors know Catalent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Catalent listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.15)

Earnings Share

(7.18)

Revenue Per Share

22.579

Quarterly Revenue Growth

(0.11)

Return On Assets

(0.01)

The market value of Catalent is measured differently than its book value, which is the value of Catalent that is recorded on the company's balance sheet. Investors also form their own opinion of Catalent's value that differs from its market value or its book value, called intrinsic value, which is Catalent's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Catalent's market value can be influenced by many factors that don't directly affect Catalent's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Catalent's value and its price as these two are different measures arrived at by different means. Investors typically determine if Catalent is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Catalent's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Catalent Stock EBITDA

Catalent Company EBITDA Analysis

EBITDA

Revenue

-

Basic Expenses

Current Catalent EBITDA

Catalent EBITDA Driver Correlations

Catalent EBITDA Historical Pattern

Catalent Ebitda

Ebitda

86.31 Million

Catalent EBITDA Peer Comparison

Catalent Institutional Holders

Catalent Fundamentals

About Catalent Fundamental Analysis

Pair Trading with Catalent

Moving against Catalent Stock

Complementary Tools for Catalent Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY